Rhythm Pharmaceuticals (RYTM) SEC Filings & 10K Form

$49.25

+0.98 (+2.03%)

(As of 09/6/2024 ET)

Compare

Recent Rhythm Pharmaceuticals SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
08/28/2024 3:30 PM	GOOD JENNIFER L (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
08/28/2024 3:31 PM	Rhythm Pharmaceuticals (Issuer) TETRAULT LYNN A. (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
08/28/2024 3:31 PM	Cramer Pamela J. (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
08/26/2024 3:26 PM	Cramer Pamela J. (Reporting) Rhythm Pharmaceuticals (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
08/26/2024 3:27 PM	Rhythm Pharmaceuticals (Subject) TETRAULT LYNN A. (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
08/26/2024 3:27 PM	GOOD JENNIFER L (Reporting) Rhythm Pharmaceuticals (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
08/13/2024 3:45 PM	Cramer Pamela J. (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
Get the Latest News and Ratings for RYTM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
08/12/2024 3:13 PM	Rhythm Pharmaceuticals (Subject) TETRAULT LYNN A. (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
08/07/2024 5:00 AM	Rhythm Pharmaceuticals (Filer)	Form DEFR14A
08/07/2024 5:03 AM	Rhythm Pharmaceuticals (Filer)	Form DEFA14A
08/06/2024 6:00 AM	Rhythm Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
07/30/2024 4:09 PM	Cramer Pamela J. (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
07/18/2024 4:59 PM	Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
07/16/2024 3:30 PM	Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
07/16/2024 3:37 PM	Rhythm Pharmaceuticals (Subject) Shulman Joseph (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
07/12/2024 3:34 PM	Rhythm Pharmaceuticals (Subject) Shulman Joseph (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
07/10/2024 4:00 PM	Garfield Alastair (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 3 Initial statement of beneficial ownership of securities
07/10/2024 4:01 PM	Garfield Alastair (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
07/10/2024 3:05 PM	Rhythm Pharmaceuticals (Filer)	Form 424B7
07/10/2024 3:07 PM	Rhythm Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
06/25/2024 3:39 PM	MCGIRR DAVID W J (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/25/2024 3:41 PM	Arbuckle Stuart A (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/25/2024 3:30 PM	GOOD JENNIFER L (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/25/2024 3:35 PM	JEAN CHRISTOPHE (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/25/2024 3:37 PM	Bedrosian Camille L (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/25/2024 3:38 PM	Mathers Edward T (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/25/2024 3:38 PM	Rhythm Pharmaceuticals (Issuer) TETRAULT LYNN A. (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/20/2024 8:44 PM	MCGIRR DAVID W J (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/20/2024 8:47 PM	Rhythm Pharmaceuticals (Issuer) TETRAULT LYNN A. (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/20/2024 8:38 PM	Arbuckle Stuart A (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/20/2024 8:39 PM	GOOD JENNIFER L (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/20/2024 8:41 PM	Bedrosian Camille L (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/20/2024 8:42 PM	JEAN CHRISTOPHE (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/20/2024 8:43 PM	Mathers Edward T (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/17/2024 4:28 PM	Rhythm Pharmaceuticals (Filer)	Form DEFA14A
06/17/2024 4:19 PM	Rhythm Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/07/2024 3:43 PM	Rhythm Pharmaceuticals (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
05/07/2024 6:10 AM	Rhythm Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
04/30/2024 6:31 PM	NEW ENTERPRISE ASSOCIATES 13 LP (Filed by) Rhythm Pharmaceuticals (Subject)	Form SC 13D/A
04/26/2024 3:13 PM	Rhythm Pharmaceuticals (Filer)	Form ARS
04/17/2024 3:15 PM	PERCEPTIVE ADVISORS LLC (Filed by) Rhythm Pharmaceuticals (Subject)	Form SC 13D/A
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032. Learn more about this much-needed advancement and investment opportunity here.
04/16/2024 7:11 PM	Mazabraud Yann (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
04/16/2024 6:00 AM	Rhythm Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
04/03/2024 7:00 PM	German Christopher Paul (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
04/03/2024 5:18 PM	PERCEPTIVE ADVISORS LLC (Filed by) Rhythm Pharmaceuticals (Subject)	Form SC 13D/A
04/01/2024 4:25 PM	Rhythm Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
03/22/2024 3:55 PM	Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
03/21/2024 3:21 PM	Rhythm Pharmaceuticals (Subject) Shulman Joseph (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
03/20/2024 4:51 PM	PERCEPTIVE ADVISORS LLC (Filed by) Rhythm Pharmaceuticals (Subject)	Form SC 13D
03/20/2024 3:41 PM	Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
03/19/2024 7:50 PM	Cramer Pamela J. (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
03/19/2024 7:52 PM	Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
03/19/2024 7:53 PM	Mazabraud Yann (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
03/19/2024 7:54 PM	Meeker David P (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
03/19/2024 7:56 PM	Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
03/19/2024 7:57 PM	Rhythm Pharmaceuticals (Issuer) Smith Hunter C (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/29/2024 3:58 PM	Rhythm Pharmaceuticals (Filer)	Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans
02/29/2024 3:44 PM	Rhythm Pharmaceuticals (Filer)	Form 424B5
02/29/2024 3:46 PM	Rhythm Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
02/29/2024 3:05 PM	Rhythm Pharmaceuticals (Filer)	Form 10-K Annual report pursuant to Section 13 or 15(d)
02/22/2024 6:01 AM	Rhythm Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
02/21/2024 6:00 PM	Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/21/2024 6:00 PM	Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/21/2024 6:01 PM	Rhythm Pharmaceuticals (Issuer) Smith Hunter C (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/21/2024 6:01 PM	Cramer Pamela J. (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/21/2024 6:02 PM	German Christopher Paul (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/21/2024 6:02 PM	Mazabraud Yann (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/21/2024 6:03 PM	Meeker David P (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/15/2024 5:14 PM	Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/13/2024 7:45 PM	Cramer Pamela J. (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/13/2024 7:46 PM	Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/13/2024 7:47 PM	Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/13/2024 7:49 PM	Mazabraud Yann (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/13/2024 7:50 PM	Rhythm Pharmaceuticals (Issuer) Smith Hunter C (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/13/2024 4:13 PM	Rhythm Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)	Form SC 13G
02/09/2024 3:19 PM	Rhythm Pharmaceuticals (Subject) Shulman Joseph (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
02/05/2024 5:53 PM	Cramer Pamela J. (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/05/2024 5:53 PM	Meeker David P (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/05/2024 5:54 PM	Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/05/2024 5:54 PM	Rhythm Pharmaceuticals (Issuer) Smith Hunter C (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/05/2024 5:55 PM	Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/05/2024 4:34 PM	GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by) Rhythm Pharmaceuticals (Subject)	Form SC 13G/A
01/24/2024 8:46 AM	BlackRock Inc. (Filed by) Rhythm Pharmaceuticals (Subject)	Form SC 13G/A
01/23/2024 8:04 AM	Rhythm Pharmaceuticals (Subject) STATE STREET CORP (Filed by)	Form SC 13G/A
01/04/2024 6:15 AM	Rhythm Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
01/04/2024 6:00 AM	Rhythm Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
01/03/2024 3:15 PM	Rhythm Pharmaceuticals (Issuer) Smith Hunter C (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
12/29/2023 3:30 PM	Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
12/27/2023 3:22 PM	Rhythm Pharmaceuticals (Subject) Shulman Joseph (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
12/18/2023 3:16 PM	Rhythm Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
12/06/2023 3:30 PM	Rhythm Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late.
12/06/2023 3:34 PM	Rhythm Pharmaceuticals (Subject) Smith Hunter C (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
11/24/2023 12:06 PM	Rhythm Pharmaceuticals (Subject) Smith Hunter C (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
11/14/2023 3:14 PM	Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
11/14/2023 3:14 PM	Rhythm Pharmaceuticals (Subject) Shulman Joseph (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
11/13/2023 4:44 PM	Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
11/08/2023 3:30 PM	Rhythm Pharmaceuticals (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
11/08/2023 3:14 PM	Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
11/07/2023 5:17 PM	Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
11/07/2023 6:05 AM	Rhythm Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)